Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
Market Cap: $294,656,782,271.18
Industry:
Track NVS stock with real-time alerts and market analysis
Current Price: $155.12